Drug Trial Radar · NCT05726097
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Last checked: Nov 19, 2026Latest source record: Feb 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
147
Actual
Start
Feb 1, 2023
Primary completion
Oct 31, 2023
Study completion Oct 31, 2023
Sponsor
- Lead sponsor
- Region SkaneAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Lund University; Odense University Hospital
- First posted
- Feb 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to investigate the effect of the optimized bowel preparation and boost regimens on colon capsule endoscopy procedures, specifically on cleanliness and completion rate.
Conditions
- Colon Cancer
- Inflammatory Bowel Diseases
- Gastrointestinal Bleed
- Colon Polyp
Interventions
polyethylene glycolDrug
colonic preparation
sodium phosphateDrug
colonic preparation
polyethylene glycol + ascorbic acidDrug
colonic preparation
gastrografinDrug
colonic preparation
magnesiumoxid + sodium picosulfateDrug
colonic preparation
prucaloprideDrug
colonic preparation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Completeness rateTime frame: Within 3 months after completed capsule colonoscopy
- Adequate cleanliness rateTime frame: Within 3 months after completed capsule colonoscopy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Skåne University Hospital
Malmö, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.